These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23819759)

  • 1. Inhibition of androgen induces autophagy in benign prostate epithelial cells.
    Li M; Yang X; Wang H; Xu E; Xi Z
    Int J Urol; 2014 Feb; 21(2):195-9. PubMed ID: 23819759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-ARI induces autophagy of prostate epithelial cells through suppressing IGF-1 expression in prostate fibroblasts.
    Yang BY; Jiang CY; Dai CY; Zhao RZ; Wang XJ; Zhu YP; Qian YX; Yin FL; Fu XY; Jing YF; Han BM; Xia SJ; Ruan Y
    Cell Prolif; 2019 May; 52(3):e12590. PubMed ID: 30883989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines.
    Maria McCrohan A; Morrissey C; O'Keane C; Mulligan N; Watson C; Smith J; Fitzpatrick JM; Watson RW
    Cancer; 2006 Jun; 106(12):2743-52. PubMed ID: 16703599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
    Geller J
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
    Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
    Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer.
    Hsieh JT; Chen SC; Yu HJ; Chang HC
    Prostate; 2011 Jul; 71(10):1115-21. PubMed ID: 21557276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
    Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for atrophy and apoptosis in the prostates of men given finasteride.
    Rittmaster RS; Norman RW; Thomas LN; Rowden G
    J Clin Endocrinol Metab; 1996 Feb; 81(2):814-9. PubMed ID: 8636309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.
    Bauman TM; Sehgal PD; Johnson KA; Pier T; Bruskewitz RC; Ricke WA; Huang W
    Prostate; 2014 Jun; 74(9):923-32. PubMed ID: 24789081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
    Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
    Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
    Gormley GJ; Stoner E; Bruskewitz RC; Imperato-McGinley J; Walsh PC; McConnell JD; Andriole GL; Geller J; Bracken BR; Tenover JS
    N Engl J Med; 1992 Oct; 327(17):1185-91. PubMed ID: 1383816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology.
    Justulin LA; Acquaro C; Carvalho RF; Silva MD; Felisbino SL
    Int J Androl; 2010 Jun; 33(3):489-99. PubMed ID: 19490185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells.
    Sutton MT; Yingling M; Vyas A; Atiemo H; Borkowski A; Jacobs SC; Kyprianou N
    Prostate; 2006 Aug; 66(11):1194-202. PubMed ID: 16652387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of caspases-3, -6, and -9 during finasteride treatment of benign prostatic hyperplasia.
    Bozec A; Ruffion A; Decaussin M; Andre J; Devonec M; Benahmed M; Mauduit C
    J Clin Endocrinol Metab; 2005 Jan; 90(1):17-25. PubMed ID: 15507514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic effects of Stauntonia hexaphylla in benign prostate hyperplasia are mediated by the regulation of androgen receptors and 5α-reductase type 2.
    Hong GL; Park SR; Jung DY; Karunasagara S; Lee KP; Koh EJ; Cho K; Park SS; Jung JY
    J Ethnopharmacol; 2020 Mar; 250():112446. PubMed ID: 31812646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
    Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
    J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium meta-arsenite induces reactive oxygen species-dependent apoptosis, necrosis, and autophagy in both androgen-sensitive and androgen-insensitive prostate cancer cells.
    Kim Y; Jeong IG; You D; Song SH; Suh N; Jang SW; Kim S; Hwang JJ; Kim CS
    Anticancer Drugs; 2014 Jan; 25(1):53-62. PubMed ID: 24100277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.